Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Cattle skin has leptin which might control skin and hair growth.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

DHT stops hair regrowth in mice, similar to human hair loss.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Estrogen can temporarily slow down hair growth but this can be reversed.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.